Type approval & clinical licence received for Siddharth-II
Panacea received Type Approval and Clinical Licence from AERB for its Linear Accelerator- Siddharth-II in 2023. Panacea also received US 510(k) clearance of Siddharth-II integrated with RFA.
Panacea received Type Approval and Clinical Licence from AERB for its Linear Accelerator- Siddharth-II in 2023. Panacea also received US 510(k) clearance of Siddharth-II integrated with RFA.